简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-12-19 18:17 BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma
2025-12-19 09:16 Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment
2025-12-18 13:37 GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners
2025-12-17 15:46 New Published Data Confirms Nemluvio® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis
2025-12-16 18:54 Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
2025-12-16 13:44 Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
2025-12-12 18:07 Tahoe Therapeutics Selects Parse Biosciences’ GigaLab to Generate 300 Million Single Cell Profiles for Large-Scale Perturbation Atlas
2025-12-11 14:43 Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
2025-12-11 14:07 Cleveland Clinic Neurological Institute and Baszucki Group Team Up to Advance Landmark Brain Study with Metabolic Health Markers
2025-12-11 14:02 Polpharma Biologics and Libbs Farmacêutica Sign Licensing Agreement for a Biosimilar for Autoimmune Diseases
2025-12-11 13:43 Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator
2025-12-10 14:51 SoluPet Inc. (SoluPet) Announces Strategic Partnership with CHC Healthcare Group (CHC) to Advance Canine Cognitive Health in Asia
2025-12-09 16:35 iFIT and F45 Training Announce Global Partnership to Bridge Digital and Studio Fitness
2025-12-09 15:42 BRUKINSA Delivers Landmark 74% 6-Year PFS in Patients with Treatment-Naïve Chronic Lymphocytic Leukemia
2025-12-09 15:37 Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
2025-12-08 15:31 Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
2025-12-08 14:51 Galderma Welcomes Increased Equity Investment From L’Oréal
2025-12-08 11:26 Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
2025-12-08 10:51 Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation
2025-12-05 16:53 Parse Biosciences Launches Evercode Whole Blood Fixation

Business Wire Weibo

Press Releases

Latest Releases